{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:34:50Z","timestamp":1795041290025,"version":"4.10.2"},"reference-count":35,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ABCD, arq. bras. cir. dig."],"abstract":"<jats:p>ABSTRACT BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease in the world and was recently renamed to emphasize its metabolic component. AIMS: This article seeks to fill the gap in specific guidelines for patients with obesity and MASLD who will undergo bariatric surgery. METHODS: A systematic search for guidelines was carried out on PubMed and Embase platforms. RESULTS: A total of 544 articles were found, of which 11 were selected according to inclusion and exclusion criteria. All 11 guidelines are from clinical societies; therefore, they do not include some necessary interpretations for bariatric patients. CONCLUSIONS: We recommend that every patient undergoing bariatric and metabolic surgery be screened initially with the Fibrosis-4 (FIB-4) score, followed by transient hepatic elastography (vibration-controlled transient elastography, VCTE), especially for those with FIB-4&gt;1.3. However, interpreting VCTE results in obese patients requires further studies to define the actual cutoff values. Enhanced Liver Fibrosis\u00ae shows promise but its availability is limited. The indication for liver biopsy during surgery needs to be individualized but it is recommended for those with changes in FIB-4 and\/or VCTE. Family screening is recommended for relatives of young patients with already advanced fibrosis. Liver transplantation is an option for patients with advanced MASLD but the optimal timing for bariatric surgery with transplantation is still unclear. Regular follow-up and VCTE examination are recommended to monitor disease progression after surgery.<\/jats:p>","DOI":"10.1590\/0102-6720202400028e1821","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T10:19:39Z","timestamp":1721384379000},"source":"Crossref","is-referenced-by-count":5,"title":["METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE \u2014 ASSESSMENT OF PATIENTS WITH OBESITY AND METABOLIC SYNDROME \u2014 GUIDELINE FROM THE BRAZILIAN SOCIETY OF BARIATRIC AND METABOLIC SURGERY"],"prefix":"10.1590","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1117-9188","authenticated-orcid":false,"given":"Leonardo","family":"HALAMY PEREIRA","sequence":"first","affiliation":[{"name":"Universidade Federal Fluminense, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0777-4530","authenticated-orcid":false,"given":"Fernando de","family":"BARROS","sequence":"additional","affiliation":[{"name":"Universidade Federal Fluminense, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1719-4211","authenticated-orcid":false,"given":"Thais Guaran\u00e1 de","family":"ANDRADE","sequence":"additional","affiliation":[{"name":"Universidade Federal Fluminense, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4409-8000","authenticated-orcid":false,"given":"Alvaro Albano de","family":"OLIVEIRA NETO","sequence":"additional","affiliation":[{"name":"Santa Casa de Miseric\u00f3rdia de Itabuna, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1355-2368","authenticated-orcid":false,"given":"Cristiane Alves Villela","family":"NOGUEIRA","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3940-1525","authenticated-orcid":false,"given":"Antonio Carlos","family":"VALEZI","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Londrina, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.21037\/tgh.2019.11.14","article-title":"Non-invasive diagnosis: non-alcoholic fatty liver disease and alcoholic liver disease.","volume":"5","author":"Altamirano J","year":"2020","journal-title":"Transl Gastroenterol Hepatol."},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.","volume":"45","author":"Angulo P","year":"2007","journal-title":"Hepatology."},{"issue":"5","key":"ref3","first-page":"1603","article-title":"Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO).","volume":"27","year":"2022","journal-title":"Eat Weight Disord."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"101547","DOI":"10.1016\/j.eclinm.2022.101547","article-title":"Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: a systematic review and meta-analysis.","volume":"51","author":"Cao YT","year":"2022","journal-title":"EClinicalMedicine."},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases.","volume":"67","author":"Chalasani N","year":"2018","journal-title":"Hepatology."},{"issue":"9","key":"ref6","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1210\/clinem\/dgac321","article-title":"Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: a meta-analysis and systematic review of 10 739 607 individuals.","volume":"107","author":"Chan KE","year":"2022","journal-title":"J Clin Endocrinol Metab."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"100139","DOI":"10.1016\/j.liver.2023.100139","article-title":"Is bariatric surgery safer before, during, or after liver transplantation? A systematic review and meta-analysis.","volume":"9","author":"Chierici A","year":"2023","journal-title":"J Liver Transpl."},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/jgh.13856","article-title":"The Asia-Pacific working party on non-alcoholic fatty liver disease guidelines 2017-part 2: management and special groups.","volume":"33","author":"Chitturi S","year":"2018","journal-title":"J Gastroenterol Hepatol."},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","article-title":"American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD).","volume":"28","author":"Cusi K","year":"2022","journal-title":"Endocr Pract."},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1007\/s11695-021-05412-y","article-title":"Gastric bypass compared with sleeve gastrectomy for nonalcoholic fatty liver disease: a systematic review and meta-analysis.","volume":"31","author":"Silva MBB","year":"2021","journal-title":"Obes Surg."},{"issue":"29","key":"ref11","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.2174\/13816128113199990381","article-title":"Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment.","volume":"19","author":"Dongiovanni P","year":"2013","journal-title":"Curr Pharm Des."},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00125-016-3902-y","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.","volume":"59","year":"2016","journal-title":"Diabetologia."},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis \u2013 2021 update.","volume":"75","year":"2021","journal-title":"J Hepatol."},{"issue":"10","key":"ref14","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41575-022-00635-5","article-title":"Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight.","volume":"19","author":"Eslam M","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s13304-021-01230-0","article-title":"Combined liver transplantation with sleeve gastrectomy: a pioneer case series from Brazil.","volume":"74","author":"Fernandes ESM","year":"2022","journal-title":"Updates Surg."},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13098-024-01259-2","article-title":"2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes.","volume":"16","author":"Godoy-Matos AF","year":"2024","journal-title":"Diabetol Metab Syndr."},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.dld.2017.01.147","article-title":"AISF position paper on nonalcoholic fatty liver disease (NAFLD): updates and future directions.","volume":"49","year":"2017","journal-title":"Dig Liver Dis."},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"e0141649","DOI":"10.1371\/journal.pone.0141649","article-title":"Evaluation of transient elastography, Acoustic Radiation Force Impulse Imaging (ARFI), and Enhanced Liver Function (ELF) score for detection of fibrosis in morbidly obese patients.","volume":"10","author":"Karlas T","year":"2015","journal-title":"PLoS One."},{"issue":"Suppl 1","key":"ref19","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.21037\/atm.2020.01.89","article-title":"Laparoscopic vertical sleeve gastrectomy, long and short-term impact on weight loss and associated co-morbidities.","volume":"8","author":"Khaitan L","year":"2020","journal-title":"Ann Transl Med."},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1053\/j.gastro.2020.06.006","article-title":"Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis.","volume":"159","author":"Lassailly G","year":"2020","journal-title":"Gastroenterology."},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"e230123","DOI":"10.20945\/2359-4292-2023-0123","article-title":"Brazilian evidence-based guideline for screening, diagnosis, treatment, and follow-up of metabolic dysfunction-associated steatotic liver disease (MASLD) in adult individuals with overweight or obesity: a joint position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Hepatology (SBH), and Brazilian Association for the Study of Obesity and Metabolic Syndrome (Abeso).","volume":"67","author":"Moreira RO","year":"2023","journal-title":"Arch Endocrinol Metab."},{"key":"ref22","series-title":"Non-alcoholic fatty liver disease: assessment and management.","year":"2016"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page MJ","year":"2021","journal-title":"BMJ."},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/hepr.13737","article-title":"Comparison of diagnostic performance between FIB-4 and NFS in metabolic-associated fatty liver disease era.","volume":"52","author":"Park H","year":"2022","journal-title":"Hepatol Res."},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis.","volume":"8","author":"Quek J","year":"2023","journal-title":"Lancet Gastroenterol Hepatol."},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multi-society Delphi consensus statement on new fatty liver disease nomenclature.","volume":"78","author":"Rinella ME","year":"2023","journal-title":"Hepatology,"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease.","volume":"77","author":"Rinella ME","year":"2023","journal-title":"Hepatology."},{"issue":"4","key":"ref28","first-page":"e1626","article-title":"Obesity and severe steatosis: the importance of biochemical exams and scores.","volume":"34","author":"Silva MBB","year":"2022","journal-title":"Arq Bras Cir Dig."},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection.","volume":"43","author":"Sterling RK","year":"2006","journal-title":"Hepatology."},{"issue":"9","key":"ref30","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/hepr.12647","article-title":"Comparison of FIB-4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non-alcoholic fatty liver disease: a meta-analysis study.","volume":"46","author":"Sun W","year":"2016","journal-title":"Hepatol Res."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e1759","DOI":"10.1590\/0102-672020230041e1759","article-title":"Brazilian multi-society position statement on emerging bariatric and metabolic surgical procedures.","volume":"36","author":"Valezi AC","year":"2023","journal-title":"Arq Bras Cir Dig."},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jhep.2020.03.036","article-title":"Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: a systematic review and meta-analysis.","volume":"73","author":"Vali Y","year":"2020","journal-title":"J Hepatol."},{"issue":"10390","key":"ref33","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0140-6736(23)00634-7","article-title":"Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial.","volume":"401","author":"Verrastro O","year":"2023","journal-title":"Lancet."},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/jgh.13857","article-title":"Asia-Pacific working party on non-alcoholic fatty liver disease guidelines 2017-part 1: definition, risk factors and assessment.","volume":"33","author":"Wong VWS","year":"2018","journal-title":"J Gastroenterol Hepatol."},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3138\/canlivj-2021-0019","article-title":"Liver biopsy complication rates in patients with non-alcoholic fatty liver disease.","volume":"5","author":"Zhou F","year":"2022","journal-title":"Can Liver J."}],"container-title":["ABCD. Arquivos Brasileiros de Cirurgia Digestiva (S\u00e3o Paulo)"],"original-title":["DOEN\u00c7A HEP\u00c1TICA ESTEAT\u00d3TICA ASSOCIADA \u00c0 DISFUN\u00c7\u00c3O METAB\u00d3LICA \u2014 AVALIA\u00c7\u00c3O DE PACIENTES PORTADORES DE OBESIDADE E S\u00cdNDROME METAB\u00d3LICA \u2014 DIRETRIZ DA SOCIEDADE BRASILEIRA DE CIRURGIA BARI\u00c1TRICA E METAB\u00d3LICA"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0102-67202024000100601&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T08:07:31Z","timestamp":1732435651000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0102-67202024000100601&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":35,"alternative-id":["S0102-67202024000100601"],"URL":"https:\/\/doi.org\/10.1590\/0102-6720202400028e1821","relation":{},"ISSN":["2317-6326","0102-6720"],"issn-type":[{"value":"2317-6326","type":"electronic"},{"value":"0102-6720","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e1821"}}